Biocorp Production Market capitalization 2024

The Biocorp Production Market capitalization history

YEAR	REVENUE (undefined EUR)	GROSS MARGIN (%)	NET INCOME (undefined EUR)
2026e	61.42	17,32	52.13
2025e	29.97	35,49	3.72
2024e	22.87	46,53	1.63
2023e	15.14	70,26	0.05
2022	11.67	91,16	-0.65
2021	10.23	97,25	0.29
2020	8.46	90,55	-1.24
2019	8.45	101,77	0.96
2018	3.89	79,79	-5.31
2017	2.32	91,23	-7.51
2016	2.95	77,27	-4.45
2015	2.46	58,30	-0.85
2014	1.65	76,97	-
2013	2.03	76,85	0.4
2012	2.02	79,21	-

Biocorp Production Aktienanalyse

What does Biocorp Production do?

Biocorp Production SA is a French company in the medical technology industry that manufactures innovative solutions for drug administration and injections. It was founded in 2004 under the name Biocorp sur mesure by Eric Dessertenne and later transformed into Biocorp Production SA. The business model of Biocorp Production SA is to produce innovative medical devices that can be used in medical applications. The company specializes in the development of smart devices that support injection administration. The devices produced by Biocorp can be operated by medical professionals or by patients themselves. One of the core areas of Biocorp Production SA is the development of smart medical technologies that aid in medication management. One such product is Vyoo, a device that assists patients in injecting medications. It is a digital device that facilitates injection administration and makes dosing safer. In addition to developing smart devices, Biocorp also offers other services, such as in the field of clinical trials for medical applications. The company works closely with pharmaceutical companies to develop medical devices and solutions for drug administration. Another important product is Mallya, an intelligent insulin administration system specifically designed for diabetes patients. It enables automated insulin administration tailored to the patient's needs, thereby improving their quality of life. Furthermore, Biocorp Production SA is also involved in the field of wearable medical technology. One example of a wearable device is Easylog, an electronic device for monitoring medical conditions. This device is particularly useful for patients with chronic diseases such as diabetes or asthma. Over the years, Biocorp Production SA has received numerous awards for its innovative products and services. For example, the company received the Innovation Award at the "Innovation Awards" in Paris in 2017 for the Mallya device. Overall, the company currently employs over 60 employees and has its headquarters in Issoire. It has branches in Germany and the USA. The products of Biocorp Production SA are sold in more than 80 countries worldwide. In summary, Biocorp Production SA is a leading provider of smart medical devices for drug administration and injections. The company strives to develop innovative solutions for the medical industry that are tailored to the needs of patients and medical professionals. With the products of Biocorp Production SA, medication administration becomes safer, easier, and more accurate. Biocorp Production ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Biocorp Production's Market Capitalization

Biocorp Production's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Biocorp Production's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Biocorp Production's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Biocorp Production’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Biocorp Production Stock

What is the current Biocorp Production market capitalization?

The current market capitalization of Biocorp Production is 154.39 M EUR.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Biocorp Production.

How has the market capitalization of Biocorp Production developed in recent years?

The market capitalization of Biocorp Production has increased/decreased by 106.47% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Biocorp Production?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Biocorp Production?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Biocorp Production have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Biocorp Production pay?

Over the past 12 months, Biocorp Production paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biocorp Production is expected to pay a dividend of 0 EUR.

What is the dividend yield of Biocorp Production?

The current dividend yield of Biocorp Production is .

When does Biocorp Production pay dividends?

Biocorp Production pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biocorp Production?

Biocorp Production paid dividends every year for the past 0 years.

What is the dividend of Biocorp Production?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biocorp Production located?

Biocorp Production is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biocorp Production kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biocorp Production from 6/29/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 6/29/2024.

When did Biocorp Production pay the last dividend?

The last dividend was paid out on 6/29/2024.

What was the dividend of Biocorp Production in the year 2023?

In the year 2023, Biocorp Production distributed 0 EUR as dividends.

In which currency does Biocorp Production pay out the dividend?

The dividends of Biocorp Production are distributed in EUR.